FILTER BY:
Details
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
Address: 3400 Civic Center Blvd West Pavilion, Philadelphia, PA 19104
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: True
- Peritoneal: False
- Pericardial: False
- Tunica Vaginalis: False
Type: Epitheliod, Biphasic, Sarcomatoid
Condition: Mesothelioma Pleural
Description: The study is a single-arm phase I trial to evaluate the safety, feasibility, and preliminary efficacy of the addition of pembrolizumab and image-guided resection to surgical therapy and chemotherapy for malignant pleural mesothelioma (MPM).
Research Center: Abramson Cancer Center of the University of Pennsylvania
Treatment Interventions: DRUG: Pembrolizumab, PROCEDURE: Indocyanine Green (ICG) Image-Guided Surgery, DRUG: Cisplatin, DRUG: Pemetrexed
Potential Impact: Low
Clinical Trial Number: NCT03760575
Phase: Phase 1
Status: Recruiting
